Can You Restart Mounjaro?
Yes—restarting Mounjaro after a break is generally possible under clinical supervision. The weight regain that follows stopping GLP-1 medications—documented clearly in the SURMOUNT-4 trial —supports the clinical case for restarting when long-term weight management is the goal.
Standard eligibility applies:
- BMI ≥ 30 (obesity), or
- BMI ≥ 27 with at least one related health condition (e.g. type 2 diabetes, hypertension)
However, many providers take a more flexible approach for previous patients—particularly those who can demonstrate prior successful treatment. For the full eligibility picture, see our Mounjaro eligibility guide.
How Break Length Affects Restarting
The length of your break determines the appropriate restart dose. This is consistent with the Mounjaro SmPC guidance on missed doses and with standard clinical practice:
| Break Length | Restart Approach |
|---|---|
| 1–2 weeks | May continue at the same dose |
| 2–4 weeks | Often restart one dose level lower |
| 4+ weeks | Restart at 2.5mg and re-titrate from the beginning |
Starting at a lower dose after a break—or returning to the lowest dose—significantly reduces the risk of gastrointestinal side effects during readaptation. Do not attempt to skip ahead to your previous dose without clinical guidance.
Restarting with a Lower BMI
If your BMI has dropped below the standard threshold during your break—or even during your previous treatment—many providers will still consider restarting you on Mounjaro, provided you can demonstrate:
- Evidence of previous prescriptions — confirmation you were legitimately treated before
- Weight loss progress and history — showing that treatment was effective and regain is occurring
- Relevant medical history — existing conditions that initially supported eligibility may still apply
This reflects the growing recognition of obesity as a chronic, relapsing condition. A patient who lost weight on Mounjaro and regained it after stopping is arguably a stronger clinical case for restart than a new patient—the medication has already demonstrated it works for them. See our guide on why BMI cutoffs alone are a flawed basis for stopping treatment.
Steps to Restart Safely
- Step 1 — Speak to a clinician: contact your original provider or a new regulated pharmacy. Explain that you are seeking to restart after a break and provide as much context as possible about your previous treatment.
- Step 2 — Provide your treatment history: gather previous prescription labels, pen box photos, order confirmations, and any clinical notes from your previous treatment. This significantly strengthens your case for lower-BMI restart.
- Step 3 — Complete a new medical consultation: this will assess your current BMI, health markers, and overall suitability for restarting. Most providers conduct this online.
- Step 4 — Restart at the appropriate dose: follow the guidance in the table above based on how long your break has been. Never skip to your previous dose without clinical approval.
- Step 5 — Monitor progress and side effects: restarting can feel similar to starting treatment for the first time. Be aware that gastrointestinal side effects may return, particularly at the 2.5mg dose.
What Pharmacies Need
Different providers have different requirements for restarting patients. Common requests include:
- Updated BMI and current weight — some providers require a recent weight measurement
- Prescription history — photos of previous pen boxes, prescription labels, or order confirmations
- Brief medical history — particularly any conditions that supported your original eligibility
- Blood tests — some providers request HbA1c or lipid panel results, particularly if considerable time has elapsed
Always confirm the specific requirements with your chosen provider before booking a consultation—requirements vary and being prepared speeds up the process significantly.
Switching Provider to Restart
If your original pharmacy cannot support a restart—for example, because their BMI eligibility criteria do not accommodate patients below threshold—switching to a different registered provider is a practical option.
When evaluating a new provider, look specifically for:
- Explicit policies on restarting patients — do they accept treatment history documentation?
- Flexible BMI criteria for previous patients — particularly important if your BMI has changed
- Long-term prescribing support — can they support your treatment beyond the initial restart phase?
- GPhC registration — verified before placing any order
For a step-by-step guide to the pharmacy switching process—including what documents to prepare—see: Switching Pharmacies for Mounjaro or Wegovy in the UK.
Related Guides
Sources & Further Reading
This guide references the following official and authoritative sources.
- 1SURMOUNT-4 trial — Weight regain after stopping tirzepatide
Clinical trial demonstrating that stopping tirzepatide led to ~14% weight regain within 12 months, supporting restart and maintenance prescribing.
- 2NICE — Tirzepatide for managing overweight and obesity (TA1026)
NICE guidance on tirzepatide eligibility, treatment duration, and continuation criteria.
- 3Mounjaro (tirzepatide) SmPC — Dosing guidance
Official UK prescribing information for Mounjaro, including dose initiation and reinitiation guidance.
- 4Mounjaro eligibility BMI guide — Health Wise
Full UK eligibility criteria for Mounjaro—BMI thresholds, conditions, ethnicity adjustments, and what happens when BMI drops.
- 5Switching pharmacies for Mounjaro or Wegovy — Health Wise
How to find a new regulated provider if your current pharmacy cannot support a restart.
Frequently Asked Questions
Can I restart Mounjaro after stopping?
Yes—restarting Mounjaro after a break is generally possible, subject to a new clinical assessment. Even if your BMI has dropped below the original eligibility threshold, many providers will consider your treatment history and previous results. The key requirement is a new medical review.
What dose should I restart Mounjaro at after a break?
It depends on the length of your break. For breaks of 1–2 weeks, you may be able to continue at the same dose. For 2–4 weeks, restarting one dose level lower is common. For breaks of 4 weeks or more, most clinicians recommend restarting at the lowest dose (2.5mg) and re-titrating gradually. This reduces the risk of side effects.
Will my BMI affect whether I can restart Mounjaro?
Possibly, but not definitively. Standard NICE eligibility criteria require BMI ≥ 30 (or ≥ 27 with a related condition). However, many providers take a more flexible approach for previous patients, considering weight history, risk of regain, and prior treatment success. Bringing documentation of your previous treatment significantly helps.
Do I need a new prescription to restart Mounjaro?
Yes—you will need a new prescription from a registered UK prescriber. Existing prescriptions cannot be reactivated; a new clinical consultation is required. Most providers offer this via an online questionnaire or video consultation.
Why did I regain weight after stopping Mounjaro?
Weight regain after stopping Mounjaro is a well-documented and expected physiological response. The SURMOUNT-4 trial showed that patients who discontinued tirzepatide regained approximately two-thirds of their lost weight within 12 months. Hunger returns to its biological set point as the medication's appetite suppression reverses. This is why long-term maintenance treatment is often clinically appropriate.
Can I restart Mounjaro at the same pharmacy or do I need a new one?
You can try to restart with your original pharmacy—but their eligibility requirements may have changed, or you may no longer meet their BMI criteria. If your original provider cannot accommodate a restart, switching to a provider with a more flexible approach to previous patients is a reasonable option.
